Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Sodium-calcium exchanger 1 (NCX1) is a critical electrogenic transporter located on the plasma membrane of sinoatrial node (SAN) cells, where it plays a pivotal role in cardiac pacemaking (UniProt P32418; PubMed 15618538). It functions by exchanging three extracellular sodium ions for one intracellular calcium ion, or vice versa, depending on the electrochemical gradient (UniProt P32418). In the context of the SAN, NCX1 is the primary link between the calcium clock and the membrane clock, as it generates an inward depolarizing current (INCX) in response to spontaneous diastolic calcium releases from the sarcoplasmic reticulum (PubMed 21685500). This current accelerates the late phase of diastolic depolarization, ensuring the timely firing of action potentials that dictate the heart rate (PubMed 15618538; StatPearls NBK541011). Dysregulation of NCX1 activity is associated with various cardiovascular conditions, including sinus node dysfunction, atrial fibrillation, and heart failure (PubMed 21685500). While no NCX-specific inhibitors are currently in widespread clinical use, experimental compounds like SEA0400 and KB-R7943 are being studied for their potential to treat arrhythmias by modulating calcium handling (PubChem CID 119541). Additionally, drugs like digoxin indirectly influence NCX1 activity by altering the sodium gradient across the cell membrane (StatPearls NBK556025).
Inhibition of the sodium-calcium exchange process to modulate intracellular calcium concentrations and the resulting electrogenic current.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium-calcium exchanger 1 (NCX1) (NCX1).